Manuela Berto Pucca, Thaís Barboza Bertolini, José Elpidio Barbosa, Simone Vasconcelos Ribeiro Galina, & Geciane Silveira Porto. (2011). Therapeutic monoclonal antibodies: ScFv patents as a marker of a new class of potential biopharmaceuticals. Universidade de São Paulo.
Chicago Style (17th ed.) CitationManuela Berto Pucca, Thaís Barboza Bertolini, José Elpidio Barbosa, Simone Vasconcelos Ribeiro Galina, and Geciane Silveira Porto. Therapeutic Monoclonal Antibodies: ScFv Patents as a Marker of a New Class of Potential Biopharmaceuticals. Universidade de São Paulo, 2011.
MLA (9th ed.) CitationManuela Berto Pucca, et al. Therapeutic Monoclonal Antibodies: ScFv Patents as a Marker of a New Class of Potential Biopharmaceuticals. Universidade de São Paulo, 2011.
Warning: These citations may not always be 100% accurate.